Skip to content
Clinical Trials – home

Intestinal infarction Diagnostics

0 / 1 trials open to patients1 country

In short

Intestinal infarction is a serious medical condition that happens when blood flow to the intestines is suddenly blocked or severely reduced, leading to tissue damage and potentially life-threatening complications. Early recognition and prompt medical attention are crucial, as this condition can progress rapidly and cause permanent harm if not treated quickly.

Key points

  • Intestinal infarction is a medical emergency with mortality rates of 60-80%, making rapid diagnosis and treatment absolutely critical for survival.
  • The hallmark symptom is sudden, severe abdominal pain that feels unbearable, even though the belly may not be very tender to touch—a puzzling mismatch that actually helps doctors recognize the condition.
  • CT scans, especially with contrast dye to visualize blood vessels, are the most valuable imaging tests for diagnosing intestinal infarction and identifying blocked arteries.
  • No blood test alone can confirm intestinal infarction, but elevated white blood cells and high lactic acid levels strongly suggest the condition is present.
  • People with irregular heart rhythms like atrial fibrillation are at especially high risk because blood clots can form in the heart and travel to intestinal arteries.
  • Sometimes exploratory surgery is the only way to definitively diagnose intestinal infarction when symptoms are severe but tests remain inconclusive—and waiting too long for more testing can be fatal.
  • Special "watershed areas" in the colon—the splenic flexure and rectosigmoid junction—are particularly vulnerable to blood flow problems and account for about 70% of ischemic colitis cases.
  • Early diagnosis before significant tissue death occurs dramatically improves survival chances, highlighting why anyone with sudden severe belly pain should seek emergency care immediately without delay.

Introduction: Who Should Seek Diagnostic Testing

Intestinal infarction, also called acute mesenteric ischemia, occurs when the blood supply to parts of the intestine becomes blocked or significantly reduced. This interruption means that intestinal tissues cannot receive enough oxygen and nutrients, which leads to damage and, if untreated, tissue death. The condition is uncommon, but it carries a very high risk of serious complications and death, with mortality rates ranging from 60% to 80% in acute cases.

Anyone experiencing sudden, severe abdominal pain should seek immediate medical attention. This type of pain is often intense and does not improve with position changes or rest. The pain may feel so severe that it becomes impossible to sit still or find comfort. Time is critical with intestinal infarction—the sooner the diagnosis is made, the better the chances of recovery and survival.

People who are at higher risk for this condition include those over 60 years of age, especially if they have heart problems or blood vessel diseases. Individuals with irregular heart rhythms such as atrial fibrillation (a condition where the heart beats irregularly) are particularly vulnerable because blood clots can form in the heart and travel to the arteries supplying the intestines. Other risk factors include having had a recent heart attack, diabetes, high blood pressure, high cholesterol, or blood clotting disorders.

The symptoms of intestinal infarction can sometimes be vague or mistaken for less serious digestive problems, which makes early diagnosis challenging. However, certain warning signs should never be ignored. These include sudden and severe abdominal pain, an urgent need to have a bowel movement, forceful or frequent bowel movements, bloody stools, diarrhea, fever, vomiting, and abdominal swelling or tenderness.

It is also important to understand that there are two main types of intestinal ischemia (reduced blood flow): acute and chronic. Acute intestinal ischemia develops rapidly, often within hours, and is the more dangerous form. Chronic intestinal ischemia develops more gradually over weeks or months, typically causing pain after eating as the intestines require more blood for digestion but cannot receive enough due to narrowed arteries.

Classic Diagnostic Methods

Diagnosing intestinal infarction can be difficult because the symptoms often resemble other, less serious digestive problems. However, healthcare professionals use a combination of physical examination, blood tests, and imaging studies to identify the condition as quickly as possible.

Physical Examination

The diagnostic process typically begins with a physical examination. During this exam, the doctor will check for tenderness, swelling, or bloating in the abdomen. One notable feature of intestinal infarction is that the pain is often severe even though the abdomen may not be very tender to touch initially. This mismatch between the intensity of pain and physical findings can be an important clue.

Blood Tests

Blood tests alone cannot definitively diagnose intestinal infarction, but certain results can suggest the condition. Doctors commonly check for a high white blood cell count, which is a marker of infection or inflammation in the body. When tissues are damaged due to lack of oxygen, the body responds by increasing white blood cells to fight potential infection.

Another important blood test looks for increased acid levels in the bloodstream, a condition called lactic acidosis. When tissues do not receive enough oxygen, they start producing lactic acid as a byproduct of abnormal metabolism. High levels of lactic acid in the blood can indicate that tissues are suffering from oxygen deprivation.

Healthcare providers may also check for signs of bleeding in the digestive tract through blood tests, as intestinal damage can cause internal bleeding.

Imaging Tests

Imaging tests are crucial for visualizing what is happening inside the body and confirming the diagnosis. Several types of imaging may be used, depending on what is available and the patient's condition.

A CT scan (computed tomography scan) of the abdomen is the most commonly used imaging test for diagnosing intestinal infarction. This test creates detailed, cross-sectional images of the abdomen and can show whether blood flow to the intestines is blocked or reduced. CT scans can also reveal complications such as dead tissue, perforation (a hole in the intestine), or infection.

Sometimes doctors use a special type of CT scan called CT angiography (CTA), which involves injecting a contrast dye into the bloodstream. The dye makes blood vessels show up more clearly on the images, allowing doctors to see exactly where blockages or narrowing have occurred.

MRI (magnetic resonance imaging) is another imaging option that can provide detailed pictures of soft tissues and blood vessels. Like CT, MRI can be combined with angiography (MRA) to better visualize blood flow patterns in the intestinal arteries.

Ultrasound, particularly Doppler ultrasound of the abdomen, uses sound waves to create images and can show blood flow in the vessels supplying the intestines. This test is non-invasive and does not use radiation, but it may not provide as much detail as CT or MRI scans.

An angiogram is a more invasive test that involves inserting a thin tube called a catheter into an artery, usually in the groin or arm. A dye is then injected through the catheter, and X-rays are taken as the dye flows through the blood vessels. This test can pinpoint exactly where blockages or narrowing exist. One advantage of angiography is that it allows doctors to treat certain blockages immediately during the same procedure, such as by removing a clot or widening a narrowed artery.

Plain X-rays of the abdomen may also be taken, though they are less helpful for early diagnosis. X-rays can sometimes show signs of complications such as dead bowel tissue or perforation, but they often appear normal in the early stages of the disease.

Endoscopic Procedures

In some cases, doctors may use an endoscope—a lighted, flexible tube with a camera on its tip—to look inside the digestive tract. During sigmoidoscopy, the scope examines the last two feet of the colon, while colonoscopy allows examination of the entire colon. These procedures can help identify inflammation, tissue damage, or bleeding in the large intestine. However, they are more commonly used when doctors suspect ischemic colitis (reduced blood flow to the colon) rather than acute infarction of the small intestine.

Exploratory Surgery

Sometimes, despite all available tests, the diagnosis remains uncertain. In such cases, or when a patient's condition is rapidly deteriorating, doctors may need to perform exploratory surgery. During surgery, the surgeon can directly examine the intestines and identify dead or damaged tissue. This approach allows both diagnosis and treatment to occur during the same procedure, which can be lifesaving.

Diagnostics for Clinical Trial Qualification

Clinical trials for intestinal infarction are relatively rare because the condition is a medical emergency that requires immediate treatment. However, when research studies do occur, they typically focus on evaluating new diagnostic methods, imaging techniques, or treatment approaches. Qualification for such trials would involve specific diagnostic criteria to ensure that participants truly have the condition being studied.

Standard diagnostic criteria for enrolling patients in research studies related to intestinal infarction typically include confirmation through imaging studies, particularly CT angiography or conventional angiography. These tests provide objective evidence of blocked or narrowed blood vessels supplying the intestines. Researchers may also require documentation of specific symptoms such as sudden severe abdominal pain, along with laboratory findings like elevated white blood cell counts or lactic acidosis.

For trials comparing different treatment approaches, participants might need to meet specific timing criteria—for example, presentation within a certain number of hours from symptom onset. This is important because the effectiveness of various treatments can depend heavily on how quickly they are administered after blood flow is disrupted.

Clinical trials may also require baseline diagnostic tests to document the extent of intestinal damage before treatment begins. These could include blood tests to measure organ function, imaging to assess which areas of the intestine are affected, and endoscopic examination to evaluate tissue damage directly. Follow-up diagnostic testing would then be performed at specified intervals to measure outcomes such as restoration of blood flow, healing of damaged tissue, and prevention of complications.

Some research studies might focus on prevention of intestinal infarction in high-risk patients, such as those with severe heart disease or clotting disorders. For these prevention trials, diagnostic criteria would include documentation of risk factors through blood tests, imaging studies of the blood vessels, and assessment of heart function through tests like electrocardiograms or echocardiograms.

Emerging research areas include the development of blood-based biomarkers—substances in the blood that indicate tissue damage or reduced blood flow—that could allow earlier diagnosis of intestinal ischemia. Clinical trials investigating these biomarkers would use both the new blood tests and standard imaging methods to determine how accurately the biomarkers can identify patients with the condition.

Prognosis and Survival Rate

Prognosis

The prognosis for intestinal infarction depends heavily on how quickly the condition is diagnosed and treated. When blood flow is restored promptly, before significant tissue death occurs, the outlook can be relatively good. However, delays in diagnosis and treatment lead to more extensive damage and worse outcomes.

Several factors affect a person's chances of recovery. The cause of the blockage plays a role—for instance, blood clots that can be removed may have better outcomes than cases involving multiple narrowed arteries due to cholesterol buildup. The extent of intestinal damage is also critical. If only a small section of intestine is affected and can be surgically removed, recovery is more likely. However, when large portions of the intestine are damaged or die, complications become much more serious.

A person's overall health and presence of other medical conditions also influence prognosis. Older adults and those with severe heart disease, diabetes, kidney failure, or other serious health problems tend to have more difficult recoveries. Patients who develop complications such as infection of the abdominal cavity (peritonitis), sepsis (a life-threatening response to infection), or perforation (a hole in the intestine) face much greater risks.

After surgery to remove dead intestinal tissue, some people may have long-term challenges with nutrient absorption, especially if a large amount of intestine had to be removed. These individuals might need special diets, nutritional supplements, or even long-term nutrition delivered through the veins. Some patients may require a temporary or permanent ostomy, where waste is diverted through an opening in the abdomen into a collection bag.

Survival rate

Intestinal infarction has a very high mortality rate, particularly when it involves the small intestine. Studies show that mortality rates for acute mesenteric ischemia range from 60% to 80%, making it one of the most lethal abdominal emergencies.

The survival rate improves significantly when the condition is caught and treated early, before extensive tissue death occurs. Patients who receive treatment within the first few hours of symptom onset have much better chances of survival than those whose diagnosis is delayed. However, even with prompt treatment, the overall mortality rate remains in the range of 50% or higher.

Patients who develop complications such as bowel perforation, severe infection, or sepsis have even lower survival rates. The need for extensive bowel resection also worsens the prognosis. On the other hand, individuals with less severe ischemic colitis (affecting the large intestine rather than the small intestine) often have better outcomes, with many cases resolving without surgery.

Long-term survival for those who recover from the acute event depends on managing underlying conditions that contributed to the intestinal infarction, such as heart disease, high blood pressure, high cholesterol, and blood clotting disorders. Patients who successfully address these risk factors through medication, lifestyle changes, and ongoing medical care have better long-term outlooks.

Did you know?

  1. Certain areas of the colon called "watershed areas" are especially vulnerable to blood flow problems because they sit at the border between territories supplied by different arteries, similar to how watershed regions separate different river drainage systems.
  2. Despite causing some of the most severe abdominal pain imaginable, early-stage intestinal infarction may produce surprisingly little tenderness when a doctor presses on the belly—a puzzling mismatch that actually helps with diagnosis.
  3. The intestines contain trillions of beneficial bacteria, but when intestinal tissue dies, these normally helpful microbes can escape into places they don't belong and cause life-threatening infections and sepsis.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Intestinal infarction

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Peritonitis+3

Not recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alanine
  • Sponsor:Rigshospitalet
See all 1 trials →filters applied: condition = Intestinal infarction

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).